Tech Company Financing Transactions

Coultreon Biopharma Funding Round

Forbion Capital Partners, Novo Holdings and Sofinnova Partners joined a $125 million Series A funding round for Coultreon Biopharma. The round was announced on 4/28/2026.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Gaston Geenslaan 3
Leuven, 3001
Belgium

Phone

+32 16 85 25 10

Website

www.coultreon.com

Email Address

[email protected]

Overview

Our team brings together extensive experience in drug discovery and development. With a proven track record of delivering best-in-class medicines, we combine deep disease biology expertise with cutting-edge technologies. The team has successfully advanced both small and large molecule programmes across various therapeutic areas

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Pierre Raboisson

        

Chief Financial Officer

Guy Peeters

        

Chief Operating Officer

Pieter Peeters

        

Co-Founder

François Gonzalvez

        

Co-Founder

Fabrice Kolb

        

Co-Founder

Joost Kolkman

        

Co-Founder

Sandrine Vendeville

        

VP - Bus. Development

John-Paul Gallivan

        

VP - General Counsel

Marie De Vulder

        

VP - Regulatory Affairs

Gert De Beckker

        

Browse more venture capital transactions:

Prev: 4/28/2026: Cybord venture capital transaction
Next: 4/28/2026: SkyfireAI venture capital transaction

Share this article

News on VC Transactions

We do our best to record every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary